Patricia Fank

Dr. Patricia Fank

Rush University Medical Center, Chicago, Illinois, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
MLMarquita W Lewis-Thames
Marquita W Lewis-Thames
PFPatricia Fank
Patricia Fank
MGMichelle Gates
Michelle Gates
KRKathy Robinson
Kathy Robinson
KDKristin Delfino
Kristin Delfino
YMYamilé Molina
Yamilé Molina
Background: Structural inequities, in part, undergird urban–rural differences in cancer care. The current study aims to understand the potential consequences of structural inequities on rural and urban cancer patients’ access to and perceived importance of supportive cancer care resources. Methods: We used data collected from November 2017 to May 2018 from a larger cross-sectional needs assessment about patients’ support needs, use of services, and perceptions at a Midwestern United States cancer center. Oncology patients received a study packet during their outpatient clinic visit, and interested patients consented and completed the questionnaires. Results: Among the sample of 326 patients, 27% of the sample was rural. In adjusted logistic regression models, rural patients were less likely to report using any secondary support services (15% vs. 27%; OR = 0.43, 95%CI [0.22, 0.85], p = 0.02) and less likely than urban counterparts to perceive secondary support services as very important (51% vs. 64%; OR = 0.57, 95%CI [0.33, 0.94], p = 0.03). Conclusion: Structural inequities likely have implications on the reduced access to and importance of supportive care services observed for rural cancer patients. To eliminate persistent urban–rural disparities in cancer care, rural residents must have programs and policies that address cancer care and structural inequities.

5 October 2024 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
SLSheila Lahijani
Sheila Lahijani
MRMaria Rueda-Lara
Maria Rueda-Lara
NMNatalie McAndrew
Natalie McAndrew
ANAshley M. Nelson
Ashley M. Nelson
MGMichelle Guo
Michelle Guo
HAHermioni L. Amonoo
Hermioni L. Amonoo
Among the potential complications of allogeneic hematopoietic stem cell transplantation (HSCT), graft-versus-host disease (GVHD) is common and associated with significant physical and psychosocial symptom burden. Despite substantial advances in GVHD treatment, the global immune suppression that frequently accompanies GVHD treatment also contributes to high rates of physical and emotional suffering and mortality. The complex manifestations of GVHD and its treatment warrant a multidisciplinary team-based approach to managing patients' multi-organ system comorbidities. A biobehavioral framework can enhance our understanding of the complex association between medications, physical symptoms, and psychosocial distress in patients with GVHD. Hence, for this perspective, we highlight the importance of addressing both the physical and psychosocial needs experienced by patients with GVHD and provide guidance on how to approach and manage those symptoms and concerns as part of comprehensive cancer care.

23 April 2025 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
LRLauren Rynar
Lauren Rynar
JKJonathan Kaplan
Jonathan Kaplan
PFPatricia Fank
Patricia Fank

24 April 2026 in Transplantation and Cellular Therapy
Verified
Journal Article
Closed access
TSTimothy S. Sannes
Timothy S. Sannes
BBBenjamin W. Brewer
Benjamin W. Brewer
LWLori Wiener
Lori Wiener
SLSheila Lahijani
Sheila Lahijani
NMNatalie S. McAndrew
Natalie S. McAndrew
HAHermioni L. Amonoo
Hermioni L. Amonoo